Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2003
03/13/2003WO2003020945A2 An enzymatic process for the synthesis of organo-fluorine compounds
03/13/2003WO2003020942A2 Process for production of r-phenylacetylcarbinol by an enzymatic process in a two-phase system
03/13/2003WO2003020931A2 Sirna knockout assay method and constructs
03/13/2003WO2003020929A1 Novel amide hydrolase gene
03/13/2003WO2003020924A2 Stable storage of proteins
03/13/2003WO2003020923A1 Xylanase variants
03/13/2003WO2003020922A2 Enzymes involved in cell wall biosynthesis in filamentous fungi
03/13/2003WO2003020921A2 Novel pyruvate decarboxylase, production and use thereof
03/13/2003WO2003020914A2 Protein phosphatase stress-related polypeptides and methods of use in plants
03/13/2003WO2003020912A2 Novel clark protein and nucleic acid molecules and uses therefor
03/13/2003WO2003020890A2 Genes encoding baeyer-villiger monooxygenases
03/13/2003WO2003020885A2 Identification of sortase gene
03/13/2003WO2003020881A2 DOMINANT NEGATIVE VARIANTS OF METHIONINE AMINOPEPTIDASE 2 (MetAP2) AND CLINICAL USES THEREOF
03/13/2003WO2003020880A2 Method of identifying inhibitors of lck
03/13/2003WO2003020764A2 Modified factor ix
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020282A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
03/13/2003WO2003020019A2 Methods and compositions for pearl oyster cultivation
03/13/2003WO2003020017A1 Identification and expression of heterologous nucleic acid sequences encoding heterologous fatty acid modifying enzymes in plants
03/13/2003WO2003020015A2 Methods to produce transgenic plants resistant to osmotic stress
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003020005A2 Lp mammalian proteins; related reagents
03/13/2003WO2002079445A3 Transgenic mice containing kallikrein-like gene disruptions
03/13/2003WO2002079431A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002079229A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002077213A3 New elongase gene and production of δ9-polyunsaturated fatty acids
03/13/2003WO2002075045B1 Method for the enzymatic control of pitch deposits formed during paper pulp production using an esterase that hydrolyses triglycerides and sterol esters
03/13/2003WO2002074979A3 Expression profiles and methods of use
03/13/2003WO2002074942A3 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
03/13/2003WO2002074935A3 Use of telomerase reverse transcriptase to create homozygous knockout animals
03/13/2003WO2002072782A3 Master activators of pathogen responsive genes
03/13/2003WO2002072634A3 Recombinant proteinase k
03/13/2003WO2002070713A3 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins
03/13/2003WO2002068616A3 Tissue transglutaminase
03/13/2003WO2002062820A3 Haplotypes of the cyp27b1 gene
03/13/2003WO2002061106A3 Method for producing cysteine, cystine and glutathione by fermentation
03/13/2003WO2002060926A3 Hepatitis c tripeptide inhibitors
03/13/2003WO2002053754A3 Human protease and polynucleotides encoding the same
03/13/2003WO2002051996A3 Regulation of human cyclophilin-like protein
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002048336A3 Short peptides from the 'a-region' of protein kinases which selectively modulate protein kinase activity
03/13/2003WO2002048330A3 21908 and 21911, human guanylate kinase family members and uses thereof
03/13/2003WO2002047717A3 Targeted enzyme prodrug therapy
03/13/2003WO2002046461A3 Method for identifying modulators of transcription
03/13/2003WO2002044409A3 Substrate linked directed evolution (slide)
03/13/2003WO2002044350A3 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
03/13/2003WO2002042471A3 Methods and materials for the synthesis of organic products
03/13/2003WO2002036755A3 Regulation of human inositolpolyphosphate 5-phosphatase
03/13/2003WO2002036731A3 Human lysosomal acid lipase
03/13/2003WO2002033056A3 Regulation of human serine-threonine protein kinase
03/13/2003WO2002031177A3 Method for synthesising peptides, peptide mimetics and proteins
03/13/2003WO2002031132A3 8843, a human dual specificity phosphatase family member and uses therefor
03/13/2003WO2002029022A3 Chlorophyllases
03/13/2003WO2002029019A3 2.5-diketo-d-gluconic acid reductases and methods of use
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002026802A3 M32404, a novel human trypsin and uses thereof
03/13/2003WO2002024925A3 69109, a novel human tyrosine phosphatase and uses therefor
03/13/2003WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002024233A3 Control of nk cell function and survival by modulation of ship activity
03/13/2003WO2002022799A3 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof
03/13/2003WO2002022661A3 NOVEL PDEs AND USES THEREOF
03/13/2003WO2002020056A3 Methods and compositions for producing a neurosalutary effect in a subject
03/13/2003WO2002018552A3 Regulation of human aminotransferase-like enzyme
03/13/2003WO2002014497A3 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use
03/13/2003WO2002008401A3 Elongase genes and uses thereof
03/13/2003WO2002008391A3 Glycerol-3-phosphate/dihydroxyacetone phosphate dual substrate acyltransferases
03/13/2003WO2002006485A3 47885, a novel human ubiquitin-activating enzyme and uses therefor
03/13/2003WO2002004615A8 Method for the production of hydroxylated collagen-like compounds
03/13/2003WO2002000913A3 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
03/13/2003WO2001096598A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
03/13/2003WO2001084463A3 Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction
03/13/2003WO2001081578A3 Novel proteins and nucleic acids encoding same
03/13/2003WO2001073074A3 18806, a novel trypsin serine protease-like molecule and uses thereof
03/13/2003US20030051274 Process for producing female-sterile plants
03/13/2003US20030051273 Salicylic acid biosynthetic genes and uses thereof
03/13/2003US20030051267 Targeted disruption of kinase suppressor of RAS
03/13/2003US20030051259 Packaging cells
03/13/2003US20030051258 Detecting agent for use in reducing or preventing ultraviolet radiation damage; obtain transgenic rodent, expose to ultraviolet radiation, administer modulating agent, monitor rodent cell for reduced cellular damage
03/13/2003US20030050464 Novel human proteases and polynucleotides encoding the same
03/13/2003US20030050462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050459 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
03/13/2003US20030050457 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050441 49938, a novel human phospholipid transporter and uses therefor
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050264 Inhibiting binding of repressor factor to a Site C repressor binding site located in the TERT(telomerase reverse transciptase) minimal promoter for upregulating, the expression of telomerase reverse transcriptase
03/13/2003US20030050260 Method for treating diabetes by reducing in vivo cathepsin L activity
03/13/2003US20030050251 A polypeptide which inhibits or reduces tumor progression and/or metastasis
03/13/2003US20030050241 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050240 Extracellular proteins, secreted proteins, membrane-bound proteins; nucleic acid molecules encoding these polypeptides, as well as vectors and host cells having those nucleic acid sequences; fusion to heterologous polypeptides; antibodies
03/13/2003US20030050239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050236 Compounds that enhance tumor death
03/13/2003US20030050231 Discovery of new human colon-associated polynucleotides, the polypeptides encoded by them, and antibodies that immuno-specifically bind these polypeptides; diagnosis/medical; anticarcinogenic, -metastasis agents; other colon diorders
03/13/2003US20030050230 A nucleic acid encoding a family (title) of kinases from a group of sixteen polypeptides; identifying a substance that modulates kinase activity; autoimmune diseases; organ transplantation, cardiovascular disease, stroke, renal failure
03/13/2003US20030049837 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells
03/13/2003US20030049828 Oncogenic protein for use in the diagnosis and treatment of tumors
03/13/2003US20030049827 Subtilisin variants
03/13/2003US20030049824 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
03/13/2003US20030049823 eNOS mutations useful for gene therapy and therapeutic screening
03/13/2003US20030049822 Cytochrome P450 monooxgenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicals and methods relating thereto
1 ... 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 ... 1416